RHY 4.76% 10.0¢ rhythm biosciences limited

CellMax Life's FirstSight CRC Blood Test (DNA), page-5

  1. 26 Posts.
    lightbulb Created with Sketch. 1
    i dont need to address your questions. if your research show there none then there is none. presentations and medical journals are useless if the medical device does not have approval for market, sale and for medical use. IMO

    the other companies may have what you are looking for but if they are not approved they still cannot sell. correct me if i am wrong but RHY already has a CE mark for europe and approval for use in NZ. the approval in australia will help with any pathway to for approval in the US.
 
watchlist Created with Sketch. Add RHY (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.